期刊文献+

PET在阿尔茨海默病中的应用价值 被引量:2

Application of PET in Alzheimer disease
暂未订购
导出
摘要 阿尔茨海默病是老年痴呆中最常见的原因。FDGPET可以探测AD与不同类型痴呆葡萄糖代谢的早期变化,用于AD的早期诊断与鉴别诊断。神经炎性斑块和神经纤维缠结是AD主要的病理学特征。淀粉样斑块PET显像可以提供AD早期的诊断信息。本文主要介绍FDG与淀粉样斑块PET显像在AD中的应用价值。 Alzheimer disease(AD)is the most common cause of dementia in the current elderly populaˉtion.FDG PET can detect early metabolic changes in AD and differential metabolic features of various dementia,and be used in the early diagnosis and differential diagnosis of AD.Neuritic plaques(NPs)and neurofibrillary tangles(NFTs)are the two most characteristic pathologic hallmarks of AD.Amyloid imaging with positron emission tomography could provide important information on early or presympˉtomatic cases of dementia.This paper will focus to evaluate the value of FDG and amyloid PET imaging in Alzheimer's disease.
出处 《中国医学计算机成像杂志》 CSCD 2004年第5期352-358,共7页 Chinese Computed Medical Imaging
关键词 阿尔茨海默病 PET显像 淀粉样斑块 应用价值 早期 常见 神经炎 诊断信息 Alzheimer disease FDG Amyloid Positron emission tomography
  • 相关文献

参考文献22

  • 1] FDDNP binding as in vivo measure of Alzheimer' s disease neuropathology. J Nucl M ed 2004; 45: 12618.Kung MP, Hou C, Zhuang ZP, et al. IMPY: an improved thioflavin - T derivative for in vivo labeling of - amyloid plaques. Brain Research 2002;956:202 ~
  • 2Agdeppa ED, Kepe V, Liu J, et al. Binding characteristic of radiofluorinated 6- diakylamino - 2 - naphthylidene derivatives as positron emission tomography imaging probes for β - amyloid plaques in Alzheimer' s disease. The Journal of Neuroscience 2001;2
  • 3Okada H, Minoshima S, Cross DJ, et al. Brain FDG PET imaging in a population - based cohort of asymptomatic subjects: initial findings. J Nucl Med 2004;45:12
  • 4Kepe V, Shoghi - Jadid K, Wu HM, et al. Global and regional [ F -
  • 5Price JC, Klunk WE, Lopresti B J, et al. In vivo quantitation of amyloid binding in humans using PET imaging and 11C -labeled pittsburch compound- B .J Nucl Med 2004; 45:43
  • 6Cho SS, Kim E J, Na DL, et al. Differences in brain metabolism and regional metabolic correlates of cognitive dysfunction between early - and late - onset Alzheimer' s disease. J Nucl Med 2004; 45: 277
  • 7Hoffman JM, Welsh - Bohmer KA, Hanson M, et al. FDG PET imaging in patients with pathologically verified dementia. J Nucl Med 2000;41: 1920- 1928
  • 8Leopez OL, Kuller LH, Fitzpatric A, et al. Evaluation of dementia in the cardiovascular health cognition study. Neuoepidemiology 2003;22: 1- 12
  • 9Small GW, Ercoli LM, Silverman DHS, et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer' s disease. Proc Natl Acad Sci 2000; 97: 6037 - 6042
  • 10Silverman DHS, Small GW. Positron emission tomography in evaluation of dementia: regional brain metabolism and long - term outcome. JAMA 2001; 286:2120 - 2127

同被引文献25

  • 1Azari NP,Pettigrew KD,Schapiro MB, et al.Early detection of Alzheimer'sdisease: a statistical approach using positron emission tomographic data[J].J Cereb Blood Flow Metab,1993,13:438-447
  • 2Loesser A,Alavi A,Lewandrowski KU,et al.Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age[J].J Nucl Med,1995,36:1141-1149
  • 3Petersen RC,Doody R, Kurz A, et al.Current concepts in mild cognitive impairment[J].Arch Neurol,2001,58:1985-1992
  • 4Kura A,Diehl J,Riemenschneider M, et al.Mild cognitive disorder.Questions of definition, diagnosis, prognosis and therapy[J].Nervenarat,2004,75:6-15
  • 5Amieva H,Letenneur L,Dartigues JF, et al.Annual rate and predictors of conversion to dementia in subuects presenting mild cognitive impairment criteria defined according to a population-based study[J].Geriatr Cogn Disord,2004,18:87-93
  • 6Petersen RC,Smith GE,Waring SC,et al.Mild cognitive impairment:clinical characterization and outcome[J].Arch Neurol,1999,56:303-308
  • 7Petersen RC.Mild cognitive impairment as a diagnostic entity.J Intern Med,256:183-194
  • 8Jelic V, Nordberg A.Early diagnosis of Alzheimer disease with positron emission tomography[J].Alzheimer Dis Assoc Disord ,2000,14 Suppl 1:109-113
  • 9Herholz K. PET studies in dementia[J].Ann Nucl Med,2003,17:79-89
  • 10Nestor PJ,Fryer TD,Ikeda M,et al.Retrosplenial cortex(BA29/30)hypometabolism in mild cognitive impairment (prodromal Alzheimer's disease)[J].Eur J Neurosci,2003,18:2663-2667

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部